| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |